This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Ji-Liang Gao: Innovator in Phagocyte Receptor Modulation
Introduction
Ji-Liang Gao is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of immunology, particularly in the modulation of human phagocyte formyl peptide receptors. His work has implications for understanding and treating inflammatory responses.
Latest Patents
Ji-Liang Gao holds a patent for T20/DP178, which is an activator of human phagocyte formyl peptide receptors. The patent describes the discovery that T20/DP178, T21/DP107, and their fragments interact with members of the formyl peptide receptor family. This interaction modulates cell migration and activation, leading to the development of novel biological tools, prophylactics, therapeutics, and methods for modulating inflammatory responses.
Career Highlights
Ji-Liang Gao is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has been pivotal in advancing the understanding of immune responses and developing potential therapeutic applications.
Collaborations
Some of his notable coworkers include Philip M. Murphy and Joost J. Oppenheim. Their collaborative efforts have contributed to the advancements in the field of immunology and receptor biology.
Conclusion
Ji-Liang Gao's innovative work in the modulation of phagocyte receptors highlights his significant role in the field of immunology. His contributions pave the way for future research and therapeutic developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile